As of 2025-07-11, the Fair Value of Vincerx Pharma Inc (VINC) is -56.14 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.10 USD, the upside of Vincerx Pharma Inc is -56,236.50%.
With the market price of 0.10 USD and our fair value calculation, Vincerx Pharma Inc (VINC) is not a good investment. Investing in VINC stocks now will result in a potential loss of 56,236.50%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -16.62 | -39.31 | -62.98 | -40.16 | -30.07 | -37.83 |
| YoY growth | -13,807.95% | -136.50% | -60.24% | 36.24% | 25.11% | -2,788.67% |
| Market Cap (mil) | 0.27 |
| P/E | |
| Forward P/E |
| EPS | -11.23 |
| Avg earnings growth rate | -2,788.67% |
| TTM earnings | -30.07 |